1.
Rakesh Popat, Dana Warcel, Jenny O’Nions, Anna Cowley, Sasha Smith, William R Tucker, Kwee Yong, Simona Degli Esposti. Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial. Haematologica 2020;105(5):e261-e263; https://doi.org/10.3324/haematol.2019.235937.